论文信息 - A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers - 字舞流文

A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers

L. Buckley | S. Carbone | D. Kadariya | B. V. Van Tassell | A. Abbate | C. Gelber | M. Halquist | G. Wohlford | Adam C Pearcy | J. Chiabrando | Virginia L. Mihalick | Dana Austin | T. Park